Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2024 financial results
Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today.
Revenues increased 31% year-over-year to $17.7 billion. Revenues increased 32% operationally.
Net income was $4.46 billion, or $0.78 per share, compared to a loss of $2.38 billion, or $0.42 per share, last year. Adjusted EPS amounted to $1.06.
Revenue and earnings beat expectations.
For the full year of 2024, Pfizer expects revenues of $61-64 billion and adjusted EPS of $2.75-2.95.
The stock gained over 1% in premarket hours on Tuesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is expected to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
Citigroup set to report Q4 2025 earnings. Here’s what to expect
Citigroup Inc. (NYSE: C) has undergone a sweeping transformation in recent years, emerging as a more streamlined and profitable financial institution. The bank's performance in recent quarters has underscored the
